Key result
Patients with rheumatoid arthritis had similar rates of comprehensive cardiovascular screening in primary care compared to matched controls without the disease (24.9% vs 25.6%, OR 0.96).
Why the study?
Are patients with rheumatoid arthritis more likely to receive cardiovascular risk factor screening in primary care compared to non-RA patients?
Cross-Sectional (n=1,599)
Yes
Are patients with rheumatoid arthritis more likely to receive cardiovascular risk factor screening in primary care compared to non-RA patients?
Despite increased vascular risk and guidelines advocating for it, patients with rheumatoid arthritis do not receive additional cardiovascular screening in primary care compared to the general population.
Answers are grounded in this paper and cite their sources.
Similar screening rates in RA despite elevated risk; leaves open whether targeted primary care strategies could close the gap.
BACKGROUND: Patients with rheumatoid arthritis (RA) are known to be at increased risk of vascular disease. It is not known whether screening for vascular risk factors occurs in primary care. The aim of this study was to determine whether guidance advocating cardiovascular screening in RA patients is being implemented in primary care. METHODS: This study was undertaken in a UK primary care consultation database. All patients with a diagnosis of RA between 2000 and 2008, and still registered with the GP practice in 2009 were matched by age, gender and GP practice to three non-RA patients. Evidence of screening for five traditional vascular risk factors (blood pressure, lipids, glucose, weight, smoking) was compared in those with and without RA using logistic regression models. A comparison was also made with diabetes. RESULTS: 401 RA patients were identified and matched to 1198 non-RA patients. No differences in the overall rates of screening were found (all five risk factors: RA 24.9% vs no RA 25.6%), but RA patients were more likely to have a smoking status recorded (67% versus 62%). In contrast, those with diabetes were up to 12 times as likely to receive vascular screening. CONCLUSIONS: Despite the excess risk of vascular disease in patients with RA being of a similar magnitude to that seen in diabetes, patients with RA did not receive additional CVD screening in primary care, although this was achieved in patients with diabetes. More emphasis needs to be placed on ensuring those with RA are actively screened for cardiovascular disease in primary care.
No takes yet. Share an insight, caveat, or question.
Monk et al. (2013) conducted a cross-sectional in Rheumatoid arthritis (n=1,599). Rheumatoid arthritis vs. Matched patients without rheumatoid arthritis was evaluated on Comprehensive cardiovascular screening (all five risk factors: blood pressure, lipids, smoking status, body weight, blood glucose) (OR 0.96, 95% CI 0.73-1.25). Patients with rheumatoid arthritis had similar rates of comprehensive cardiovascular screening in primary care compared to matched controls without the disease (24.9% vs 25.6%, OR 0.96).
Synapse has enriched 10 related papers. Consider them for comparative context: